HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Air pollution and dementia in older adults in the Ginkgo Evaluation of Memory Study.

AbstractINTRODUCTION:
Growing evidence implicates air pollution as a risk factor for dementia, but prior work is limited by challenges in diagnostic accuracy and assessing exposures in the decades prior to disease development. We evaluated the impact of long-term fine particulate matter (PM2.5 ) exposures on incident dementia (all-cause, Alzheimer's disease [AD], and vascular dementia [VaD]) in older adults.
METHODS:
A panel of neurologists adjudicated dementia cases based on extensive neuropsychological testing and magnetic resonance imaging. We applied validated fine-scale air pollutant models to reconstructed residential histories to assess exposures.
RESULTS:
An interquartile range increase in 20-year PM2.5 was associated with a 20% higher risk of dementia (95% confidence interval [CI]: 5%, 37%) and an increased risk of mixed VaD/AD but not AD alone.
DISCUSSION:
Our findings suggest that air pollutant exposures over decades contribute to dementia and that effects of current exposures may be experienced years into the future.
AuthorsErin O Semmens, Cindy S Leary, Annette L Fitzpatrick, Sindana D Ilango, Christina Park, Claire E Adam, Steven T DeKosky, Oscar Lopez, Anjum Hajat, Joel D Kaufman
JournalAlzheimer's & dementia : the journal of the Alzheimer's Association (Alzheimers Dement) Vol. 19 Issue 2 Pg. 549-559 (02 2023) ISSN: 1552-5279 [Electronic] United States
PMID35436383 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Copyright© 2022 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
Chemical References
  • Air Pollutants
  • Particulate Matter
Topics
  • Humans
  • Aged
  • Ginkgo biloba
  • Air Pollution (adverse effects)
  • Air Pollutants (adverse effects, analysis)
  • Alzheimer Disease (epidemiology, chemically induced)
  • Particulate Matter (adverse effects, analysis)
  • Dementia, Vascular (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: